Drug:
Reaction: THERAPY INTERRUPTED
20260101 - 20261231
No. 601 - 700
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 601 | 26864355 |
GB |
1 | |
Spinal osteoarthritis, Therapy interrupted, Pain in extremity, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, |
||||
| 602 | 26864362 |
US |
2 | |
Migraine, Therapy interrupted, |
||||
ERENUMAB-AOOE, |
||||
| 603 | 26864366 |
US |
2 | |
Therapy interrupted, Migraine, |
||||
ERENUMAB-AOOE, |
||||
| 604 | 26864375 |
US |
34 | 1 |
Arthritis, Therapy interrupted, Psoriasis, |
||||
BIMEKIZUMAB, |
||||
| 605 | 26864567 |
US |
46 | 2 |
Lupus nephritis, Pulmonary embolism, Infection, Renal pain, Urinary tract infection, Proteinuria, Glomerular filtration rate decreased, Hypotension, Myalgia, Gait inability, Burning sensation, Pain in extremity, Blood cholesterol increased, Therapy interrupted, |
||||
VOCLOSPORIN, VOCLOSPORIN, LOSARTAN, |
||||
| 606 | 26864637 |
US |
1 | |
Disability, Therapy interrupted, Pruritus, |
||||
APREMILAST, |
||||
| 607 | 26864674 |
US |
2 | |
Product packaging quantity issue, Asthma, Therapy interrupted, Dyspnoea, Wrong technique in product usage process, Inappropriate schedule of product administration, |
||||
BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
| 608 | 26864885 |
US |
55 | 1 |
Pain, Therapy interrupted, |
||||
RELUGOLIX, RELUGOLIX, DAROLUTAMIDE, DENOSUMAB, |
||||
| 609 | 26865133 |
US |
||
Hypersomnia, Fatigue, Therapy interrupted, |
||||
BUROSUMAB, BUROSUMAB, NALTREXONE HYDROCHLORIDE AND BUPROPION HYDROCHLORIDE, METHYLPHENIDATE, METHYLPHENIDATE HYDROCHLORIDE, |
||||
| 610 | 26865725 |
US |
68 | 2 |
Product storage issue, Therapy interrupted, |
||||
ABATACEPT, ATORVASTATIN CALCIUM, LOSARTAN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, |
||||
| 611 | 26866142 |
2 | ||
Therapy interrupted, Surgery, |
||||
ADALIMUMAB, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, SPIRONOLACTONE, |
||||
| 612 | 26866311 |
US |
79 | |
Hospitalisation, Therapy interrupted, |
||||
MITOMYCIN, MITOMYCIN, MITOMYCIN, MITOMYCIN, MITOMYCIN, |
||||
| 613 | 26866526 |
2 | ||
Hospitalisation, Therapy interrupted, |
||||
LENALIDOMIDE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OXYCODONE, TIZANIDINE, |
||||
| 614 | 26866585 |
US |
79 | 2 |
Device defective, Therapy interrupted, |
||||
ABATACEPT, |
||||
| 615 | 26867059 |
EU |
76 | 1 |
Diplegia, Limb discomfort, Therapy cessation, Therapy interrupted, |
||||
| 616 | 26867233 |
2 | ||
Therapy interrupted, Peripheral swelling, Fatigue, Rib fracture, Neck injury, Loss of personal independence in daily activities, Syncope, General physical health deterioration, |
||||
MACITENTAN, RIOCIGUAT, OZANIMOD HYDROCHLORIDE, |
||||
| 617 | 26867236 |
83 | 1 | |
Pneumonia, Therapy interrupted, |
||||
AVACOPAN, |
||||
| 618 | 26867261 |
US |
70 | 2 |
Shoulder arthroplasty, Fall, Compression fracture, Pain, Therapy interrupted, Sciatica, |
||||
ETANERCEPT, |
||||
| 619 | 26867480 |
US |
21 | 1 |
Skin irritation, Papule, Pain, Therapy interrupted, Product availability issue, Product dispensing issue, |
||||
CLINDAMYCIN PHOSPHATE, CLINDAMYCIN PHOSPHATE GEL USP, 1%, CLINDAMYCIN PHOSPHATE TOPICAL, |
||||
| 620 | 26867663 |
BR |
50 | 2 |
Shoulder fracture, Therapy interrupted, Fear, |
||||
DENOSUMAB, |
||||
| 621 | 26867667 |
CA |
2 | |
Corneal transplant, Therapy interrupted, |
||||
ZOLEDRONIC ACID, |
||||
| 622 | 26870173 |
1 | ||
Rheumatoid arthritis, Therapy interrupted, Loss of personal independence in daily activities, |
||||
ADALIMUMAB-ADAZ, |
||||
| 623 | 26870333 |
|||
Therapy interrupted, Adverse drug reaction, Viral infection, Brain injury, |
||||
AMBRISENTAN, VALACYCLOVIR, VALACYCLOVIR HYDROCHLORIDE, |
||||
| 624 | 26870452 |
55 | 1 | |
Injection site bruising, Pyrexia, Pain, Pruritus, Therapy interrupted, |
||||
DUPILUMAB, |
||||
| 625 | 26870550 |
51 | 2 | |
Therapy interrupted, Molluscum contagiosum, Optic neuritis, Nystagmus, |
||||
FINGOLIMOD HCL, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE, OZANIMOD HYDROCHLORIDE, ERGOCALCIFEROL, |
||||
| 626 | 26870796 |
2 | ||
Fatigue, Asthenia, Diarrhoea, Nail disorder, Onychoclasis, Blood electrolytes decreased, Therapy interrupted, |
||||
ABEMACICLIB, |
||||
| 627 | 26870982 |
|||
Osteomyelitis, Decubitus ulcer, Bedridden, Colostomy, Paraplegia, Therapy interrupted, Leukaemia recurrent, Full blood count increased, Hypotension, Depression, |
||||
DASATINIB, |
||||
| 628 | 26872354 |
37 | 2 | |
Tuberculosis, Therapy interrupted, |
||||
ADALIMUMAB, |
||||
| 629 | 26872426 |
72 | 2 | |
Neoplasm malignant, Therapy interrupted, Mass, |
||||
RISANKIZUMAB-RZAA, |
||||
| 630 | 26878471 |
78 | 1 | |
Therapy interrupted, Ejection fraction decreased, |
||||
MAVACAMTEN, |
||||
| 631 | 26878600 |
56 | 2 | |
Therapy interrupted, Socioeconomic precarity, Malaise, Hypophagia, Activities of daily living decreased, Influenza like illness, Fall, |
||||
OFATUMUMAB, |
||||
| 632 | 26858042 |
GB |
34 | |
Crohn^s disease, Lower respiratory tract infection, Asthenia, Intentional dose omission, Product dose omission issue, Product use issue, Therapy interrupted, Product prescribing issue, Product distribution issue, |
||||
ADALIMUMAB-AATY, ADALIMUMAB-AATY, |
||||
| 633 | 26858165 |
US |
30 | 2 |
Rheumatoid arthritis, Expired device used, Drug dose omission by device, Therapy interrupted, Wrong technique in product usage process, |
||||
ETANERCEPT, ETANERCEPT, ETANERCEPT, |
||||
| 634 | 26858228 |
GB |
2 | |
Rheumatoid arthritis, Illness, Therapy interrupted, Fall, |
||||
CERTOLIZUMAB PEGOL, |
||||
| 635 | 26858234 |
US |
45 | 1 |
Psoriatic arthropathy, Therapy interrupted, Psoriasis, |
||||
ETANERCEPT, ETANERCEPT, |
||||
| 636 | 26858412 |
US |
79 | 1 |
Surgery, Therapy interrupted, |
||||
VIBEGRON, |
||||
| 637 | 26858815 |
ZM |
28 | 1 |
Drug resistance, Photophobia, Therapy interrupted, Lacrimation increased, Photophobia, Eye pain, |
||||
LINEZOLID, PRETOMANID, |
||||
| 638 | 26859158 |
US |
87 | 2 |
Therapy interrupted, Malaise, |
||||
| 639 | 26859184 |
US |
79 | |
Post procedural haemorrhage, Therapy interrupted, |
||||
MITOMYCIN, MITOMYCIN, MITOMYCIN, MITOMYCIN, |
||||
| 640 | 26859245 |
US |
||
Feeling cold, Pain, Device dislocation, Therapy interrupted, |
||||
MITOMYCIN, |
||||
| 641 | 26859507 |
US |
1 | |
Death, Hospitalisation, Loss of personal independence in daily activities, Therapy interrupted, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 642 | 26859529 |
US |
1 | |
Condition aggravated, Therapy interrupted, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 643 | 26859796 |
US |
55 | 2 |
Adverse event, Insurance issue, Therapy interrupted, |
||||
ABATACEPT, |
||||
| 644 | 26860169 |
US |
37 | 2 |
Anxiety, Therapy interrupted, |
||||
LINEZOLID, |
||||
| 645 | 26860509 |
US |
2 | |
Exophthalmos, Therapy interrupted, Eye inflammation, |
||||
TEPROTUMUMAB, TEPROTUMUMAB, |
||||
| 646 | 26860553 |
2 | ||
Knee operation, Therapy interrupted, |
||||
BOSUTINIB, |
||||
| 647 | 26860725 |
2 | ||
Therapy interrupted, Surgery, |
||||
PIRTOBRUTINIB, |
||||
| 648 | 26861283 |
GB |
43 | 1 |
Rheumatoid arthritis, Therapy interrupted, Product prescribing issue, |
||||
CERTOLIZUMAB PEGOL, |
||||
| 649 | 26861409 |
84 | 2 | |
Fall, Weight bearing difficulty, Movement disorder, Therapy interrupted, Hallucination, Confusional state, Delirium, Therapy cessation, Cognitive disorder, |
||||
PIMAVANSERIN TARTRATE, PIMAVANSERIN TARTRATE, |
||||
| 650 | 26861477 |
US |
87 | 2 |
Blood potassium increased, Therapy interrupted, Feeling abnormal, Abdominal pain upper, Joint swelling, Blood creatinine increased, |
||||
SODIUM ZIRCONIUM CYCLOSILICATE, |
||||
| 651 | 26861570 |
2 | ||
Therapy interrupted, Hospitalisation, |
||||
SOMATROPIN, |
||||
| 652 | 26861763 |
US |
53 | |
Hospitalisation, Therapy interrupted, |
||||
| 653 | 26862286 |
US |
75 | 1 |
Endotracheal intubation, Myocardial infarction, Coronary artery occlusion, Therapy interrupted, Product dispensing issue, Product physical issue, |
||||
ICOSAPENT ETHYL, ICOSAPENT ETHYL, |
||||
| 654 | 26862543 |
US |
56 | 1 |
Inability to afford medication, Therapy interrupted, |
||||
| 655 | 26864772 |
1 | ||
Surgery, Therapy interrupted, Drug effect less than expected, Diarrhoea, Gastric dilatation, |
||||
TIRZEPATIDE, |
||||
| 656 | 26865074 |
2 | ||
Therapy interrupted, Peripheral swelling, Fatigue, Pleural effusion, Nonspecific reaction, |
||||
DASATINIB, |
||||
| 657 | 26865138 |
63 | 1 | |
Heart failure with preserved ejection fraction, Cardiac failure, Pneumonitis, Therapy interrupted, Respiratory failure, COVID-19, |
||||
EVEROLIMUS, EVEROLIMUS TABLETS, EVEROLIMUS, EVEROLIMUS TABLETS, EVEROLIMUS, EVEROLIMUS TABLETS, FUROSEMIDE, PREDNISONE, GLIPIZIDE, INSULIN GLARGINE, INSULIN ASPART, LABETALOL, |
||||
| 658 | 26865406 |
71 | 2 | |
Therapy interrupted, Surgery, |
||||
ABALOPARATIDE, |
||||
| 659 | 26865408 |
69 | 2 | |
Therapy interrupted, |
||||
ABALOPARATIDE, |
||||
| 660 | 26865409 |
66 | 2 | |
Chemotherapy, Therapy interrupted, |
||||
AVACOPAN, |
||||
| 661 | 26865760 |
34 | 2 | |
Loss of consciousness, Dizziness, Nausea, Dehydration, Flank pain, Therapy interrupted, |
||||
MACITENTAN, TREPROSTINIL, |
||||
| 662 | 26865864 |
75 | 2 | |
Therapy interrupted, Respiratory syncytial virus infection, |
||||
LENALIDOMIDE, |
||||
| 663 | 26865950 |
82 | 1 | |
Pneumonia, Therapy interrupted, |
||||
LENALIDOMIDE, |
||||
| 664 | 26866006 |
2 | ||
Dyspnoea, Therapy interrupted, |
||||
MACITENTAN, |
||||
| 665 | 26866007 |
56 | 2 | |
Therapy interrupted, Thinking abnormal, Fatigue, Asthenia, Pain, Seizure, |
||||
OFATUMUMAB, |
||||
| 666 | 26870624 |
84 | 2 | |
Intestinal obstruction, Therapy interrupted, |
||||
LENALIDOMIDE, |
||||
| 667 | 26870985 |
71 | 2 | |
Fall, Seizure, Foot fracture, Therapy interrupted, |
||||
GABAPENTIN, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, HYDROXYZINE HYDROCHLORIDE ORAL, |
||||
| 668 | 26852444 |
CA |
31 | |
Rheumatoid arthritis, Symptom recurrence, Pain, Inappropriate schedule of product administration, Underdose, Overdose, Suspected off label use, Therapy interrupted, Product prescribing issue, |
||||
INFLIXIMAB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, DICLOFENAC SODIUM, |
||||
| 669 | 26852542 |
US |
2 | |
Withdrawal syndrome, Chills, Hyperhidrosis, Temperature regulation disorder, Nausea, Headache, Eating disorder, Insomnia, Dysphoria, Skin irritation, Therapy interrupted, |
||||
DEXTROMETHORPHAN HYDROBROMIDE, BUPROPION HYDROCHLORIDE, BUPROPION, |
||||
| 670 | 26852712 |
US |
||
Therapy interrupted, |
||||
ADALIMUMAB-AATY, ADALIMUMAB-AATY, |
||||
| 671 | 26852826 |
US |
2 | |
Pneumonia, Upper respiratory tract infection, Stomatitis, Cough, Weight decreased, Adverse drug reaction, Therapy interrupted, |
||||
BRENSOCATIB, AMIKACIN, FAMOTIDINE, LIFITEGRAST, METHIMAZOLE, PANTOPRAZOLE, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, TOBRAMYCIN, TOBRAMYCIN SOLUTION, TOBRAMYCIN SULFATE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 672 | 26852827 |
US |
58 | 2 |
Joint swelling, Insurance issue, Arthralgia, Therapy interrupted, Rheumatoid arthritis, |
||||
ABATACEPT, |
||||
| 673 | 26853010 |
US |
85 | 2 |
Urinary tract infection, Urinary incontinence, Illness, Feeling abnormal, Feeling jittery, Diarrhoea, Nausea, Therapy interrupted, |
||||
VIBEGRON, |
||||
| 674 | 26853194 |
US |
72 | |
Infection, Flank pain, Pain, Therapy interrupted, |
||||
MITOMYCIN, MITOMYCIN, MITOMYCIN, MITOMYCIN, |
||||
| 675 | 26853629 |
CA |
78 | |
Fall, Off label use, Therapy interrupted, |
||||
USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, |
||||
| 676 | 26853639 |
CA |
65 | |
Hip arthroplasty, Diverticulitis, Hypertension, Lumbar spinal stenosis, Intentional dose omission, Off label use, Therapy interrupted, |
||||
INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, |
||||
| 677 | 26853708 |
CO |
65 | 1 |
Platelet count decreased, Therapy interrupted, |
||||
ROMIPLOSTIM, |
||||
| 678 | 26853845 |
US |
52 | 1 |
Crohn^s disease, Endoscopy capsule retention, Colorectal adenoma, Therapy interrupted, |
||||
INFLIXIMAB, INFLIXIMAB, |
||||
| 679 | 26853886 |
GB |
31 | 1 |
Crohn^s disease, Therapy interrupted, |
||||
USTEKINUMAB, |
||||
| 680 | 26854239 |
US |
64 | 1 |
Product dispensing issue, Therapy interrupted, |
||||
LENALIDOMIDE, |
||||
| 681 | 26854255 |
US |
45 | 1 |
Ill-defined disorder, Therapy interrupted, Insurance issue, Off label use, |
||||
EPINEPHRINE, ADRENALINUM, |
||||
| 682 | 26854556 |
US |
2 | |
Cholecystectomy, Gastrooesophageal reflux disease, Abdominal discomfort, Nausea, Drug intolerance, Therapy interrupted, |
||||
AMIFAMPRIDINE PHOSPHATE, AZELASTINE, DICLOFENAC, DICLOFENAC SODIUM, DONEPEZIL HYDROCHLORIDE, LEVOMILNACIPRAN HYDROCHLORIDE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, CLONAZEPAM, METHOCARBAMOL, METHOCARBAMOL TABLETS, NAPROXEN, NAPROXEN SODIUM, PANTOPRAZOLE, PREGABALIN, QUETIAPINE, MONTELUKAST SODIUM, TIMOLOL, LATANOPROST, LIFITEGRAST, ABALOPARATIDE, METHAZOLAMIDE, |
||||
| 683 | 26854717 |
US |
1 | |
Lymphoma, Malaise, Therapy interrupted, |
||||
ACALABRUTINIB, |
||||
| 684 | 26854727 |
US |
65 | 1 |
Tremor, Agraphia, Therapy interrupted, |
||||
RELUGOLIX, RELUGOLIX, |
||||
| 685 | 26855322 |
2 | ||
Surgery, Therapy interrupted, |
||||
ABATACEPT, |
||||
| 686 | 26855325 |
80 | 1 | |
Haemoptysis, Lung opacity, Pneumonitis, Pneumonia, Cough, Therapy interrupted, |
||||
DARATUMUMAB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, LENALIDOMIDE, PRASUGREL, |
||||
| 687 | 26855566 |
US |
52 | 1 |
Therapy interrupted, Pain, Loss of personal independence in daily activities, |
||||
APREMILAST, APREMILAST, |
||||
| 688 | 26855684 |
JP |
80 | |
Fracture, Therapy interrupted, |
||||
ROMOSOZUMAB-AQQG, DENOSUMAB, |
||||
| 689 | 26856104 |
2 | ||
Urinary tract infection, Therapy interrupted, |
||||
BELZUTIFAN, |
||||
| 690 | 26856558 |
71 | 2 | |
Nausea, Arthralgia, Musculoskeletal stiffness, Localised infection, Post procedural infection, Therapy interrupted, |
||||
ABATACEPT, |
||||
| 691 | 26856692 |
US |
51 | 2 |
Psoriatic arthropathy, Chemotherapy, Therapy interrupted, Memory impairment, Drug dose omission by device, |
||||
ETANERCEPT, ETANERCEPT, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
| 692 | 26856743 |
CA |
1 | |
Psoriatic arthropathy, Therapy interrupted, |
||||
APREMILAST, |
||||
| 693 | 26857269 |
US |
69 | 1 |
Product distribution issue, Therapy interrupted, |
||||
LENALIDOMIDE, |
||||
| 694 | 26861981 |
83 | 2 | |
Haematological infection, Therapy interrupted, |
||||
LENALIDOMIDE, |
||||
| 695 | 26862058 |
60 | 2 | |
Weight decreased, Therapy interrupted, |
||||
LENALIDOMIDE, |
||||
| 696 | 26862075 |
71 | 2 | |
Illness, Arthralgia, Joint stiffness, Therapy interrupted, Localised infection, Immune system disorder, |
||||
ABATACEPT, |
||||
| 697 | 26862076 |
68 | 1 | |
Respiratory syncytial virus infection, Therapy interrupted, |
||||
LENALIDOMIDE, |
||||
| 698 | 26862077 |
75 | 2 | |
Diverticulitis, Therapy interrupted, |
||||
UPADACITINIB, |
||||
| 699 | 26862205 |
84 | 2 | |
Dyspnoea, Renal impairment, Therapy interrupted, |
||||
| 700 | 26862317 |
71 | 2 | |
Illness, Arthralgia, Joint stiffness, Therapy interrupted, Localised infection, Immune system disorder, Procedural complication, |
||||
ABATACEPT, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30